FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely phthisiology. For treating bronchial tuberculosis in patients with pulmonary tuberculosis 7 days after initiation of the anti-tuberculosis therapy, inhalations are additionally conducted through a nebuliser with a preparation of hyaneb® 7 ml 2 times per day 2 hours after the injection of the anti-tuberculosis preparations in morning and 1 hour after the dinner, for 10 consecutive days, followed by course repeat 10 days later.
EFFECT: method provides higher clinical effectiveness in the early stages, as well as reducing or reducing the length of eliminating respiratory manifestations of the disease, increasing the rate of reducing the bronchial pathology.
1 cl, 3 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATMENT OF PULMONARY TUBERCULOSIS MULTIPLE DRUG-RESISTANCE OF TUBERCULOSIS MYCOBACTERIA | 2018 |
|
RU2687743C1 |
METHOD OF TREATING PULMONARY AND BRONCHIAL TUBERCULOSIS IN VARIOUS X-RAY SYNDROMES | 2023 |
|
RU2826098C1 |
METHOD FOR DIAGNOSING AND TREATING BRONCHIAL HYPERACTIVITY IN SMOKERS AND NON-SMOKERS WITH PULMONARY TUBERCULOSIS | 2023 |
|
RU2822712C1 |
METHOD OF DETERMINING THE TIMING OF SURGICAL INTERVENTION WHEN USING SHORT COURSES OF CHEMOTHERAPY FOR THE TREATMENT OF PULMONARY TUBERCULOSIS | 2022 |
|
RU2798945C1 |
METHOD FOR SELECTING SHORTENED CHEMOTHERAPY REGIMENS FOR THE TREATMENT OF PULMONARY TUBERCULOSIS | 2022 |
|
RU2805496C1 |
METHOD FOR PREVENTION OF BRONCHOPLEURAL FISTULA AFTER RIGHT-SIDED PNEUMONECTOMY IN DESTRUCTIVE PULMONARY TUBERCULOSIS WITH DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS | 2021 |
|
RU2786336C1 |
METHOD FOR FORMATION OF SHORTENED REGIMENS OF CHEMOTHERAPY FOR RESPIRATORY TUBERCULOSIS WITH MULTIPLE AND EXTENSIVE DRUG RESISTANCE OF MBT IN OLDER CHILDREN AND ADOLESCENTS | 2020 |
|
RU2748957C1 |
AUTOLOGOUS COMPOSITION AND METHOD FOR TREATING PULMONARY TUBERCULOSIS WITH DRUG RESISTANCE OF THE PATHOGEN AND ABSENCE OF EFFECT AGAINST THE BACKGROUND OF POLYCHEMOTHERAPY | 2020 |
|
RU2771843C2 |
METHOD FOR DETERMINING THE GENETIC PREDISPOSITION TO THE DEVELOPMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS MYCOBACTERIUM TUBERCULOSIS IN HIV INFECTION | 2020 |
|
RU2750715C1 |
METHOD FOR DETERMINING DURATION OF CHEMOTHERAPY OF RESPIRATORY TUBERCULOSIS WITH MULTIPLE AND WIDE MTB DRUG RESISTANCE IN CHILDREN AND TEENAGERS | 2018 |
|
RU2680972C1 |
Authors
Dates
2020-07-23—Published
2019-12-23—Filed